Gossamer Bio
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $95,842 | $0 | $6,784 | $0 |
Gross Profit | 94,850 | -986 | 5,778 | -1,101 |
EBITDA | 53,079 | -41,959 | -38,021 | -35,577 |
EBIT | 52,087 | -42,945 | -39,027 | -36,678 |
Net Income | 49,232 | -41,928 | -48,148 | -40,008 |
Net Change In Cash | 95,842 | 0 | 6,784 | 0 |
Free Cash Flow | 116,348 | -52,302 | -33,364 | -34,524 |
Cash | 86,877 | 38,863 | 32,109 | 82,609 |
Basic Shares | 238,543 | 225,735 | 225,409 | 192,883 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -4,385 | -4,429 | -5,167 | -4,268 |
EBITDA | -172,152 | -215,433 | -214,489 | -207,314 |
EBIT | -173,759 | -219,862 | -219,656 | -211,582 |
Net Income | -179,817 | -240,228 | -249,076 | -251,584 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -70,977 | -302,988 | 351,522 | |
Free Cash Flow | -159,158 | -187,507 | -190,511 | -201,243 |
Cash | 32,109 | 111,973 | 183,403 | 486,055 |
Basic Shares | 152,621 | 84,574 | 74,843 | 68,510 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | $0.22 |
2024-03-31 | -$0.19 |
2023-12-31 | -$0.21 |
2023-09-30 | -$0.21 |
